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Alessandro FiocchiThis is my first editorial as the new Editor-in-Chief of the
World Allergy Organization Journal (WAO Journal), and I
must begin with a thank you to the previous Editor-in-
Chief, Professor Lanny Rosenwasser. He had set for the
Journal a high standard that I pledge to maintain and to
develop further. During his tenure, the Journal was estab-
lished as an open-access resource and became indexed in
PubMed Central and PubMed as well as other open source
indexes, and the number of articles increased significantly,
making it a regular publication in its new online-only form.
Both Professor Rosenwasser and our first Editor-in-Chief,
Professor Johannes Ring, will thankfully stay involved as
Founding Editors, so the Journal will have the opportunity
to continue to profit from their combined experience.
In addition, I would like to reciprocate the wishes to
Professor Rosenwasser [1] for a fruitful presidency. In
the next two years he will lead an organization that has
measurably expanded. What was done during the last
presidencies to recruit excellent resources for the
World Allergy Organization (WAO) is an unparalleled
effort among the medical scientific societies. The team
built under the presidency of Professor G. Walter
Canonica, with the formation of the Special Commit-
tees, paved the way to the creation of authoritative
guidelines in his time and throughout the presidencies
of Professor Richard F. Lockey and Professor Ruby
Pawankar. This made the organization an influential
collaborator with patient organizations, regulatory au-
thorities, and industry everywhere. During the past
two years, WAO established several scientific initia-
tives and position papers focusing on severe and com-
plex allergies, [2] nurtured connections with a number
of national and regional allergy societies, in particular
in Asia and Africa, organized high caliber scientific
meetings, and promoted initiatives both in countries
where allergic disease is a big health problem and in
countries where it is growing in prevalence and sever-
ity [3]. This was due to the dedicated efforts of a wise
leadership led by Professor Ruby Pawankar. This gaveCorrespondence: allerg@tin.it
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initiative, the development of Guidelines on Atopic
Disease Prevention (GLAD-P), in line with her vision
which included a focus on disease prevention.
I have no doubt that the new presidency will further ex-
tend the WAO horizons. Thus, while Professor Rosenwas-
ser is receiving a growing organization, I am taking the
leadership of a very interesting and growing Journal, now
entering its seventh year of publication, with a substantial
number of articles covering the main topics of our discip-
line, i.e., (in decreasing order of citations) asthma, allergic
rhinitis, food allergy, immunotherapy, and drug allergy.
Most important, the WAO Journal is ready for citation
analysis toward acquiring its Impact Factor.
Being the official organ of the World Allergy
Organization, WAO Journal is intended to mirror the pro-
fessional and academic interests of our members. It will
also be a platform for viewing the development of allergic
disease in the world. As a pediatric allergist active in the
last 25 years, I have experienced the clinical impact of
the increase of this new class of diseases: increasing
number of patients, increasing complexity of cases, and
new allergic pathologies. To exemplify, our generation
witnessed the appearance of the Oral Allergy Syndrome
[4], the Food Protein-Induced Enterocolitis Syndrome,
[5] and Eosinophilic Oesophagitis [6]. As a reader of the
allergy literature, I would have hardly imagined 25 years
ago that in 2012 we would have 23 indexed allergy jour-
nals, with appreciable to high ranking impact factors.
The WAO Journal will profit from the tremendous ad-
vancements reflected in these journals and will attempt to
keep the reader updated on the different aspects of allergy
diagnosis, interpretation, and treatment. For diagnosis and
treatment, in particular, the availability of molecular tools
opens new avenues to a better interpretation of the disease
[7], the formulation of new forms of specific immunother-
apy [8], and the generation of molecular treatments able
to target very specific aspects of allergic disease [9]. Specif-
ically, the new Deputy Editor of WAO Journal, Professor
Erika Jensen-Jarolim, as an expert in the field has followed
the progress of diagnostics and molecular therapy since
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clinical interpretation of molecular-based diagnostics. This
is one of the main interests of WAO, as focused on in a
recent consensus document [11]. WAO is assembling a
strong Editorial Board which Erika and I are proud of. It
will profit from the experience of young researchers as
well as of prominent scientists and former presidents of
the organization. One of them, Professor Michael Kaliner
(President, 2005–2007), will be Series Editor for the new
section he initiated and launched, “WAO International
Case-based Discussions”, [12] aimed to illuminate the dif-
ferent perspectives of the same clinical problem from the
different parts of the world.
The causes of allergy epidemics are far from being fully
understood and remain a real mystery of modern life [13].
I am sure that research on the etiology and mechanisms
of allergic disease (s) will be one of the major topics of
WAO Journal over the next few years. In this respect, we
have still to learn from epidemiologic studies that are be-
ing actively developed. The comparison among the allergy
trends in the different parts of the world will be particu-
larly interesting in this regard, and the Journal is the nat-
ural place for comparative epidemiologic studies [14,15].
All active individual members of the 92 WAO Member
Societies are members of WAO. This Journal is their pub-
lication. It is your publication. Thus, I encourage you to
participate in the WAO Journal endeavor to publish works
with specific clinical relevance and practical measures that
are critical for the practice of allergy anywhere in the
world.
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